Page last updated: 2024-11-03

proglumide and Diabetes Mellitus, Adult-Onset

proglumide has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies

Proglumide: A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
proglumide : A racemate composed of equal amounts of (R)- and (S)-proglumide. A non-selective CCK antagonist that was used primarily for treatment of stomach ulcers, but has been replaced by newer drugs.
N(2)-benzoyl-N,N-dipropyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-benzoylglutamic acid with dippropylamine.

Research Excerpts

ExcerptRelevanceReference
"In patients with NIDDM, Trelan G-75 ingestion increased CCK concentration, but the peak level was lower, albeit insignificantly, than that of normal subjects."2.68Oral glucose ingestion stimulates cholecystokinin release in normal subjects and patients with non-insulin-dependent diabetes mellitus. ( Fujii, M; Hasegawa, H; Koide, M; Nakamura, T; Okabayashi, Y; Otsuki, M; Shirohara, H, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasegawa, H1
Shirohara, H1
Okabayashi, Y1
Nakamura, T1
Fujii, M1
Koide, M1
Otsuki, M1

Trials

1 trial available for proglumide and Diabetes Mellitus, Adult-Onset

ArticleYear
Oral glucose ingestion stimulates cholecystokinin release in normal subjects and patients with non-insulin-dependent diabetes mellitus.
    Metabolism: clinical and experimental, 1996, Volume: 45, Issue:2

    Topics: Administration, Oral; Adult; Atropine; Blood Glucose; Case-Control Studies; Cholecystokinin; Diabete

1996